» Articles » PMID: 27215212

Association of Common Genetic Variation in the Protein C Pathway Genes with Clinical Outcomes in Acute Respiratory Distress Syndrome

Overview
Journal Crit Care
Specialty Critical Care
Date 2016 May 25
PMID 27215212
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Altered plasma levels of protein C, thrombomodulin, and the endothelial protein C receptor are associated with poor clinical outcomes in patients with acute respiratory distress syndrome (ARDS). We hypothesized that common variants in these genes would be associated with mortality as well as ventilator-free and organ failure-free days in patients with ARDS.

Methods: We genotyped linkage disequilibrium-based tag single-nucleotide polymorphisms in the ProteinC, Thrombomodulin and Endothelial Protein C Reptor Genes among 320 self-identified white patients of European ancestry from the ARDS Network Fluid and Catheter Treatment Trial. We then tested their association with mortality as well as ventilator-free and organ-failure free days.

Results: The GG genotype of rs1042580 (p = 0.02) and CC genotype of rs3716123 (p = 0.002), both in the thrombomodulin gene, and GC/CC genotypes of rs9574 (p = 0.04) in the endothelial protein C receptor gene were independently associated with increased mortality. An additive effect on mortality (p < 0.001), ventilator-free days (p = 0.01), and organ failure-free days was observed with combinations of these high-risk genotypes. This association was independent of age, severity of illness, presence or absence of sepsis, and treatment allocation.

Conclusions: Genetic variants in thrombomodulin and endothelial protein C receptor genes are additively associated with mortality in ARDS. These findings suggest that genetic differences may be at least partially responsible for the observed associations between dysregulated coagulation and poor outcomes in ARDS.

Citing Articles

TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients.

Cao F, Zhang L, Zhao Z, Shen X, Xiong J, Yang Z Front Immunol. 2024; 15:1408406.

PMID: 38887291 PMC: 11180774. DOI: 10.3389/fimmu.2024.1408406.


Dysregulated Coagulation and Fibrinolysis Are Present in Patients Admitted to the Emergency Department with Acute Hypoxemic Respiratory Failure: A Prospective Study.

Keskinidou C, Vassiliou A, Papoutsi E, Jahaj E, Dimopoulou I, Siempos I Biomedicines. 2024; 12(5).

PMID: 38791043 PMC: 11118913. DOI: 10.3390/biomedicines12051081.


Evolution of multiple omics approaches to define pathophysiology of pediatric acute respiratory distress syndrome.

Whitney J, Lee I, Lee J, Kong S Elife. 2022; 11.

PMID: 35913450 PMC: 9342956. DOI: 10.7554/eLife.77405.


Thrombomodulin is associated with increased mortality and organ failure in mechanically ventilated children with acute respiratory failure: biomarker analysis from a multicenter randomized controlled trial.

Monteiro A, Flori H, Dahmer M, Sim M, Quasney M, Curley M Crit Care. 2021; 25(1):271.

PMID: 34344416 PMC: 8330123. DOI: 10.1186/s13054-021-03626-1.


Nucleotide polymorphism in ARDS outcome: a whole exome sequencing association study.

Xu J, Liu A, Wu Z, Xie J, Qu X, Li C Ann Transl Med. 2021; 9(9):780.

PMID: 34268393 PMC: 8246154. DOI: 10.21037/atm-20-5728.


References
1.
Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P . Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000; 161(2 Pt 1):454-62. DOI: 10.1164/ajrccm.161.2.9712038. View

2.
Ware L, Matthay M . The acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1334-49. DOI: 10.1056/NEJM200005043421806. View

3.
Khadaroo R, Marshall J . ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin. 2002; 18(1):127-41. DOI: 10.1016/s0749-0704(03)00069-1. View

4.
Nuckton T, Alonso J, Kallet R, Daniel B, Pittet J, Eisner M . Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002; 346(17):1281-6. DOI: 10.1056/NEJMoa012835. View

5.
Schoenfeld D, Bernard G . Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002; 30(8):1772-7. DOI: 10.1097/00003246-200208000-00016. View